Infinity Capital Management

Infinity Capital Management is an investment management and private equity organization rather than a drug-development biotech, pharma, or healthcare operating company. Publicly available information indicates it has been referenced as an equity investment platform associated with Huafa Group and has participated as an investor in life sciences companies such as Laekna Therapeutics. The company appears to focus on fund management and investment activities, not on discovering, developing, manufacturing, or commercializing therapeutic products. As a result, it does not have a clinical pipeline, therapeutic modalities, molecular targets, or indications of its own in the usual biotech-company sense.